Praxis Precision Medicines, Inc.

Developing therapies for CNS disorders using insights from genetic epilepsies.

PRAX | US

Overview

Corporate Details

ISIN(s):: US74006W2070
LEI:
Country:: United States of America
Address:: 99 HIGH STREET, 30TH FLOOR, 2110 BOSTON
Website:: https://praxismedicines.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Praxis Precision Medicines is a clinical-stage biopharmaceutical company developing therapies for central nervous system (CNS) disorders. The company's core strategy involves translating insights from genetic epilepsies to treat conditions characterized by neuronal excitation-inhibition imbalance. Praxis's approach is guided by four principles: focusing on human genetics, utilizing translational tools for validation, applying patient-guided development, and pursuing efficient clinical pathways. Its developmental pipeline includes multiple clinical-stage assets and early-stage programs aimed at delivering treatments for patients with complex brain disorders.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Praxis Precision Medicines, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Praxis Precision Medicines, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Praxis Precision Medicines, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Denali Therapeutics Inc. Developing therapies for neurodegenerative diseases that cross the blood-brain barrier.	United States of America	DNLI
Dermapharm Holding SE Manufactures patent-free branded pharmaceuticals & healthcare products for niche markets.	Germany	DMP
Dermata Therapeutics, Inc. Develops OTC skin treatments using a unique delivery technology from freshwater sponges.	United States of America	DRMA
Design Therapeutics, Inc. Develops small molecule genomic medicines to treat serious genetic diseases by modulating genes.	United States of America	DSGN
Deutsche Biotech Innovativ AG Develops biomarker-driven therapeutics and diagnostics for serious diseases with unmet needs.	Germany	DBI
DEVA HOLDİNG A.Ş. Global manufacturer of human/veterinary pharmaceuticals, APIs, and medical ampoules.	Spain	DEVA
Devyser Diagnostics Develops & sells genetic DNA test kits for labs in oncology, transplant & reproductive health.	Sweden	DVYSR
DiaMedica Therapeutics Inc. Developing a novel protein therapy for acute ischemic stroke and preeclampsia.	United States of America	DMAC
Diamyd Medical AB (publ) Developing precision immunotherapies to preserve insulin in autoimmune diabetes.	Sweden	DMYD
Dianthus Therapeutics, Inc. /DE/ Developing selective antibody therapies for severe autoimmune diseases.	United States of America	DNTH